Canton Strategic Holdings (CNTN) Common Equity (2020 - 2026)
Canton Strategic Holdings (CNTN) posted Common Equity of $469.8 million for Q1 2026, up 18.06% on a QoQ basis from $397.9 million in Q4 2025, and up 57767.37% year-over-year from N/an in Q1 2025.
Canton Strategic Holdings (CNTN) Common Equity (2020 - 2026) Analysis & Trends
Canton Strategic Holdings' Common Equity history runs 7 years deep, the most recent figure standing at $469.8 million for Q1 2026.
- Quarterly Common Equity rose 57767.37% year-over-year to $469.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $469.8 million (up 57767.37% YoY) and the FY2025 annual result came in at $397.9 million, up 30330.8% from the prior year.
- Common Equity was $469.8 million for Q1 2026 at Canton Strategic Holdings, up from $397.9 million in the prior quarter.
- Across five years, Common Equity topped out at $469.8 million in Q1 2026 and bottomed at -$814671.0 in Q1 2025.
- A 5-year average of $55.3 million and a median of $6.2 million in 2025 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2025 — Common Equity tumbled 111.56% — and 2026, when it jumped 57767.37%.
- Canton Strategic Holdings' Common Equity stood at $5.5 million in 2022, then surged by 64.72% to $9.1 million in 2023, then plunged by 85.68% to $1.3 million in 2024, then soared by 30330.8% to $397.9 million in 2025, then advanced by 18.06% to $469.8 million in 2026.
- Business Quant data shows CNTN's Common Equity at $469.8 million in Q1 2026, $397.9 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 469.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 469.80 Mn |
| Dec 31, 2025 | 397.93 Mn |
| Sep 30, 2025 | 6.15 Mn |
| Jun 30, 2025 | 367,359.00 |
| Mar 31, 2025 | -814,671.00 |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 6.69 Mn |
| Mar 31, 2024 | 7.05 Mn |
| Dec 31, 2023 | 9.13 Mn |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 3.07 Mn |
| Mar 31, 2023 | 3.20 Mn |
| Dec 31, 2022 | 5.54 Mn |
| Sep 30, 2022 | 7.12 Mn |
| Jun 30, 2022 | 9.04 Mn |
| Mar 31, 2022 | 10.34 Mn |
| Dec 31, 2021 | -4.68 Mn |
| Sep 30, 2021 | -7.14 Mn |
| Jun 30, 2021 | -6.30 Mn |